PM Group reports strong pipeline of work for 2025

PM Group reports strong pipeline of work for 2025

PM Group CEO, Anthony O'Rourke, CFO Rosita Fennell & Chairman Brendan Jennings.

The PM Group reported an operating profit of €34.8m last year on the back of strong growth in Ireland, Europe and the US.

The project delivery firm said overall revenue was €494m with all operating regions delivering profits in 2024. The Dublin-headquartered firm said trading in 2025 remains positive with a strong pipeline of projects. 

The Irish operation, accounting for approximately 63% of PM Group’s activity, remained buoyant in 2024, with robust continued investment by multinational clients. This team supports projects in Ireland and across our international footprint.

The PM Group has a heavy focus on the life sciences sector, including pharmaceutical and food companies and growth in data centres on the back of demand for AI services.

The company said it had broadened its service offering in Switzerland and Germany, supporting major life science projects and new data centre investments. "Overall, Europe’s pipeline remains healthy, driven by growth and continued investment across the continent."

The US saw continued growth of its Philadelphia office and the establishment of a new office in Raleigh-Durham, North Carolina. Major project last year included the commencement of large-scale design projects in New Jersey, Maryland and North Carolina. "The USA life sciences market represents a strategic opportunity and PM Group is well positioned to capitalise on this growth," the company said.

CEO of PM Group, Anthony O'Rourke, said: “Our largest market, Ireland, experienced continued growth and multinational client investment, while our Europe region had a very good year with broad-based revenue growth. The UK team contributed strongly to major projects internationally through our multi-office execution model."

“In the USA, we continue to expand our footprint as we deliver high-profile projects for clients in the world’s largest life sciences market. In 2025, we are seeing increasing opportunities to bid for substantial projects in the USA, given our existing track record with USA companies and the wave of large-scale investment announcements.

The company said there is a healthy pipeline of projects across key sectors, services and regions into 2025 and they are expanding their business in the USA and Europe.

"Overall, 2025 is anticipated to provide a strong foundation for PM Group’s new 2029 strategy, and the company is confident of continuing its steady growth trajectory in its major markets, " the company said.

x

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited